JP2019521156A5 - - Google Patents

Download PDF

Info

Publication number
JP2019521156A5
JP2019521156A5 JP2019502063A JP2019502063A JP2019521156A5 JP 2019521156 A5 JP2019521156 A5 JP 2019521156A5 JP 2019502063 A JP2019502063 A JP 2019502063A JP 2019502063 A JP2019502063 A JP 2019502063A JP 2019521156 A5 JP2019521156 A5 JP 2019521156A5
Authority
JP
Japan
Prior art keywords
patient
pharmaceutical composition
secukinumab
weeks
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019502063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019521156A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/054333 external-priority patent/WO2018015880A1/en
Publication of JP2019521156A publication Critical patent/JP2019521156A/ja
Publication of JP2019521156A5 publication Critical patent/JP2019521156A5/ja
Priority to JP2022100449A priority Critical patent/JP2022126791A/ja
Priority to JP2023172063A priority patent/JP2024001125A/ja
Priority to JP2025058479A priority patent/JP2025102888A/ja
Pending legal-status Critical Current

Links

JP2019502063A 2016-07-19 2017-07-18 Ｉｌ−１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 Pending JP2019521156A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022100449A JP2022126791A (ja) 2016-07-19 2022-06-22 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2023172063A JP2024001125A (ja) 2016-07-19 2023-10-03 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2025058479A JP2025102888A (ja) 2016-07-19 2025-03-31 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662364007P 2016-07-19 2016-07-19
US62/364,007 2016-07-19
PCT/IB2017/054333 WO2018015880A1 (en) 2016-07-19 2017-07-18 Methods of treating new-onset plaque type psoriasis using il-17 antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022100449A Division JP2022126791A (ja) 2016-07-19 2022-06-22 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法

Publications (2)

Publication Number Publication Date
JP2019521156A JP2019521156A (ja) 2019-07-25
JP2019521156A5 true JP2019521156A5 (https=) 2020-08-27

Family

ID=59677269

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019502063A Pending JP2019521156A (ja) 2016-07-19 2017-07-18 Ｉｌ−１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2022100449A Withdrawn JP2022126791A (ja) 2016-07-19 2022-06-22 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2023172063A Pending JP2024001125A (ja) 2016-07-19 2023-10-03 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2025058479A Pending JP2025102888A (ja) 2016-07-19 2025-03-31 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022100449A Withdrawn JP2022126791A (ja) 2016-07-19 2022-06-22 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2023172063A Pending JP2024001125A (ja) 2016-07-19 2023-10-03 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2025058479A Pending JP2025102888A (ja) 2016-07-19 2025-03-31 Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法

Country Status (6)

Country Link
US (2) US20190194311A1 (https=)
EP (2) EP4477265A3 (https=)
JP (4) JP2019521156A (https=)
CN (1) CN109476733A (https=)
ES (1) ES2992409T3 (https=)
WO (1) WO2018015880A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018015880A1 (en) * 2016-07-19 2018-01-25 Novartis Ag Methods of treating new-onset plaque type psoriasis using il-17 antagonists
CN120241997A (zh) 2019-02-18 2025-07-04 伊莱利利公司 治疗性抗体制剂
US20220267432A1 (en) * 2019-07-30 2022-08-25 Jiangsu Hengrui Medicine Co., Ltd. Method for treating autoimmune disease by il-17 antagonist
EP3797779A1 (en) * 2019-09-30 2021-03-31 Servei de Salut de Les Illes Balears - Ibsalut Combined therapy comprising an inhibitor of interleukin-17 activity and a vitamin d receptor agonist
CA3162052A1 (en) * 2019-12-06 2021-06-10 Novartis Ag Methods of treating lichen planus using interleukin-17 (il-17) antagonists
CN113769082A (zh) * 2020-06-10 2021-12-10 上海君实生物医药科技股份有限公司 抗il-17a抗体药物组合物及其用途
CN113855807A (zh) * 2021-10-25 2021-12-31 孙良丹 一种试剂在制备治疗/抑制银屑病药物中的应用
WO2025222170A1 (en) * 2024-04-19 2025-10-23 Zb17 Llc Methods of treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0417487D0 (en) 2004-08-05 2004-09-08 Novartis Ag Organic compound
GB0425569D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Biological products
EP1963368B3 (en) 2005-12-13 2020-06-10 Eli Lilly And Company Anti-il-17 antibodies
BRPI0706788A2 (pt) 2006-01-31 2011-04-05 Novartis Ag anticorpos antagonistas il-17
GB0612928D0 (en) 2006-06-29 2006-08-09 Ucb Sa Biological products
NZ591484A (en) 2008-09-29 2012-09-28 Roche Glycart Ag Antibodies against human il 17 and uses thereof
CN103154031A (zh) 2010-10-08 2013-06-12 诺华有限公司 利用il-17拮抗剂治疗牛皮癣的方法
EP2791170A1 (en) 2011-12-16 2014-10-22 Synthon Biopharmaceuticals B.V. Compounds and methods for treating inflammatory diseases
LT2953969T (lt) 2013-02-08 2019-12-10 Novartis Ag Anti-il-17a antikūnai ir jų panaudojimas autoimuninių ir uždegiminių ligų gydymui
WO2014155278A2 (en) 2013-03-26 2014-10-02 Novartis Ag Methods of treating autoimmune diseases using il-17 antagonists
WO2015022656A1 (en) 2013-08-15 2015-02-19 Novartis Ag Methods of treating generalized pustular psoriasis (gpp) using il-17 antagonists
AR103173A1 (es) * 2014-12-22 2017-04-19 Novarits Ag Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
WO2018015880A1 (en) 2016-07-19 2018-01-25 Novartis Ag Methods of treating new-onset plaque type psoriasis using il-17 antagonists

Similar Documents

Publication Publication Date Title
JP2019521156A5 (https=)
CN103458926B (zh) 改进的高浓度抗TNF α 抗体液体制剂
JP6554155B2 (ja) Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法
RU2017108173A (ru) Комбинированная терапия на основе антител, активирующих человеческий cd40, и антител к человеческому pd-l1
RU2008141433A (ru) Терапия опухолей с использованием сосудистого эндотелиального фактора роста и антитела к рецептору типа 2 человеческого эпителиального фактора роста
JP2024001125A (ja) Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2020510039A5 (https=)
JP2022532927A5 (https=)
JP2016505572A5 (https=)
RU2012108108A (ru) Концентрированные полипептидные лекарственные формы с пониженной вязкостью
JP2021523881A5 (https=)
JP2009538916A5 (https=)
JP2024542777A5 (https=)
KR20200083996A (ko) 인터류킨-17(il-17)을 사용하여 건병증을 치료하는 방법
US20250122270A1 (en) Intradermal administration of immunoglobulin g preparation
JP2005529152A5 (https=)
JP2021528399A5 (https=)
RU2019108441A (ru) Режим дозирования
JP2024500912A5 (https=)
WO2021018191A1 (zh) Il-17拮抗剂治疗自身免疫疾病的方法
CA3187136A1 (en) Methods of treating thyroid eye disease and graves' orbitopahy using interleukin-17 (il-17) antagonists
RU2023102788A (ru) Лечение гнойного гидраденита с использованием антагонистов il-17
RU2020134794A (ru) Способы лечения хронической спонтанной крапивницы с применением лигелизумаба
TW202611068A (zh) 頭頸部異位性皮膚炎的治療
JP2020517648A5 (https=)